Search

Your search keyword '"Marazzato, Massimiliano"' showing total 160 results

Search Constraints

Start Over You searched for: Author "Marazzato, Massimiliano" Remove constraint Author: "Marazzato, Massimiliano" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
160 results on '"Marazzato, Massimiliano"'

Search Results

1. Role of Gut Microbota in Etiopathogenesis of Chronic Intestinal Psueudo Obstruction

2. Women Skin Microbiota Modifications during Pregnancy

3. Contributors

6. Chronic intestinal pseudo-obstruction: associations with gut microbiota and genes expression of intestinal serotonergic pathway

10. Poliprotect vs Omeprazole in the Relief of Heartburn, Epigastric Pain, and Burning in Patients Without Erosive Esophagitis and Gastroduodenal Lesions: A Randomized, Controlled Trial

13. Poliprotect vs Omeprazole in the relief of heartburn, epigastric pain and burning in patients without erosive esophagitis and gastro-duodenal lesions: A Randomized, Controlled Trial

14. Exploiting Bacteria for Improving Hypoxemia of COVID-19 Patients

15. Gut Microbiota Structure and Metabolites, Before and After Treatment in Early Rheumatoid Arthritis Patients: A Pilot Study

17. Genetic Diversity of Antimicrobial Resistance and Key Virulence Features in Two Extensively Drug-Resistant Acinetobacter baumannii Isolates

20. Su1635 PATIENTS WITH NONEROSIVE HEARTBURN AND EPIGATRIC PAIN SYNDROME (EPS) ARE NOT CLINICALLY DISTINGUISHABLE AND BENEFIT OF THE SAME TREATMENT. RCT POST HOC ANALYSIS DATA

21. Mo1318 THE MUCOSAL PROTECTIVE AGENT POLIPROTECT IS AN EFFECTIVE TREATMENT TO MANAGE PPI DE-PRESCRIBING. IN NON-EROSIVE HEARTBURN AND EPIGASTRIC PAIN SYNDROME PATIENTS. RCT POST HOC ANALYSIS DATA

22. Oral Bacteriotherapy Reduces the Occurrence of Chronic Fatigue in COVID-19 Patients

24. Chronic Intestinal Pseudo-Obstruction: Is There a Connection with Gut Microbiota?

26. Oxygen Sparing Effect of Bacteriotherapy in COVID-19

31. Nanoemulsions of Satureja montana Essential Oil: Antimicrobial and Antibiofilm Activity against Avian Escherichia coli Strains

32. Oral Bacteriotherapy in Patients With COVID-19: A Retrospective Cohort Study

34. 16S Metagenomics Reveals Dysbiosis of Nasal Core Microbiota in Children With Chronic Nasal Inflammation: Role of Adenoid Hypertrophy and Allergic Rhinitis

36. Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19

37. Diet Supplementation, Probiotics, and Nutraceuticals in SARS-CoV-2 Infection: A Scoping Review

38. Nasal Microbiota in RSV Bronchiolitis

39. Bovine Lactoferrin Pre-Treatment Induces Intracellular Killing of AIEC LF82 and Reduces Bacteria-Induced DNA Damage in Differentiated Human Enterocytes

40. Characterization of the Ear Canal Bacterial Flora Present in Hearing Aids (HA) Wearing Subjects

43. Coriander (Coriandrum sativum) Essential Oil: Effect on Multidrug Resistant UropathogenicEscherichia coli

46. Characterization of mucosa-associated and fecal microbiota of children with autism spectre disorder

48. When asthma and rhinitis coexist, could rhinitis reduce asthma control in children?

50. The Adherent/Invasive Escherichia coli Strain LF82 Invades and Persists in Human Prostate Cell Line RWPE-1, Activating a Strong Inflammatory Response

Catalog

Books, media, physical & digital resources